AMLODIPINE AND ATORVASTATIN and RENAL FAILURE

Overview

RENAL FAILURE is the #16 most commonly reported adverse reaction for AMLODIPINE AND ATORVASTATIN, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 102 FDA adverse event reports linking AMLODIPINE AND ATORVASTATIN to RENAL FAILURE. This represents approximately 1.6% of all 6,537 adverse event reports for this drug.

Patients taking AMLODIPINE AND ATORVASTATIN who experience renal failure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

RENAL FAILURE is a less commonly reported adverse event for AMLODIPINE AND ATORVASTATIN, but still significant enough to appear in the safety profile.

Other Side Effects of AMLODIPINE AND ATORVASTATIN

In addition to renal failure, the following adverse reactions have been reported for AMLODIPINE AND ATORVASTATIN:

• DIZZINESS — 181 reports
• NAUSEA — 175 reports
• DRUG INEFFECTIVE — 174 reports
• FATIGUE — 167 reports
• MALAISE — 161 reports
• PAIN — 143 reports
• DYSPNOEA — 141 reports
• DEATH — 137 reports
• HYPERTENSION — 129 reports
• HEADACHE — 127 reports

Other Drugs Associated with RENAL FAILURE

The following drugs have also been linked to renal failure in FDA adverse event reports:

Does AMLODIPINE AND ATORVASTATIN cause RENAL FAILURE?

RENAL FAILURE has been reported as an adverse event in 102 FDA reports for AMLODIPINE AND ATORVASTATIN. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is RENAL FAILURE with AMLODIPINE AND ATORVASTATIN?

RENAL FAILURE accounts for approximately 1.6% of all adverse event reports for AMLODIPINE AND ATORVASTATIN, making it a notable side effect.

What should I do if I experience RENAL FAILURE while taking AMLODIPINE AND ATORVASTATIN?

If you experience renal failure while taking AMLODIPINE AND ATORVASTATIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages